These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 11406105

  • 41. Role of membrane lipid distribution in chlorpromazine-induced shape change of human erythrocytes.
    Chen JY, Huestis WH.
    Biochim Biophys Acta; 1997 Jan 31; 1323(2):299-309. PubMed ID: 9042352
    [Abstract] [Full Text] [Related]

  • 42. Alteration Young's moduli by protein 4.1 phosphorylation play a potential role in the deformability development of vertebrate erythrocytes.
    Tang F, Lei X, Xiong Y, Wang R, Mao J, Wang X.
    J Biomech; 2014 Oct 17; 47(13):3400-7. PubMed ID: 25242130
    [Abstract] [Full Text] [Related]

  • 43. Effects of cyclodextrins on chlorpromazine-induced haemolysis and central nervous system responses.
    Uekama K, Irie T, Sunada M, Otagiri M, Iwasaki K, Okano Y, Miyata T, Kasé Y.
    J Pharm Pharmacol; 1981 Nov 17; 33(11):707-10. PubMed ID: 6118408
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Role of Se in stabilization of human erythrocyte membrane skeleton.
    Yang FY, Wo WH.
    Biochem Int; 1987 Aug 17; 15(2):475-82. PubMed ID: 2829904
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Toxic effect of puromycin on erythrocyte membranes which is unrelated to inhibition of protein synthesis.
    Burka ER, Ballas SK, Sabesin SM.
    Blood; 1975 Jan 17; 45(1):21-7. PubMed ID: 803107
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Direct alteration of erythrocyte membrane properties by 1-chloro-2,4-dinitrobenzene without oxidant challenge.
    Chiu DT, Lai KM, Xu CM, Liour SS, Lee J, Liu TZ.
    Exp Hematol; 1993 Jan 17; 21(1):114-8. PubMed ID: 8417947
    [Abstract] [Full Text] [Related]

  • 53. Kinetics and thermodynamics of chlorpromazine interaction with lipid bilayers: effect of charge and cholesterol.
    Martins PT, Velazquez-Campoy A, Vaz WL, Cardoso RM, Valério J, Moreno MJ.
    J Am Chem Soc; 2012 Mar 07; 134(9):4184-95. PubMed ID: 22296285
    [Abstract] [Full Text] [Related]

  • 54. The influence of chlorpromazine on the potential-induced shape change of human erythrocyte.
    Hartmann J, Glaser R.
    Biosci Rep; 1991 Aug 07; 11(4):213-21. PubMed ID: 1760529
    [Abstract] [Full Text] [Related]

  • 55. Differential inhibition of calmodulin-sensitive phosphodiesterase and Ca++-adenosine triphosphatase by chlorpromazine-linked calmodulin.
    Prozialeck WC, Wallace TL, Weiss B.
    J Pharmacol Exp Ther; 1987 Oct 07; 243(1):171-9. PubMed ID: 2822896
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Endocytosis in erythrocytes and their ghosts.
    Schrier SL, Hardy B, Bensch KG.
    Prog Clin Biol Res; 1979 Oct 07; 30():437-49. PubMed ID: 531034
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.